ATE75141T1 - Waesserige abfuehrende loesung. - Google Patents

Waesserige abfuehrende loesung.

Info

Publication number
ATE75141T1
ATE75141T1 AT88305942T AT88305942T ATE75141T1 AT E75141 T1 ATE75141 T1 AT E75141T1 AT 88305942 T AT88305942 T AT 88305942T AT 88305942 T AT88305942 T AT 88305942T AT E75141 T1 ATE75141 T1 AT E75141T1
Authority
AT
Austria
Prior art keywords
solution
liter
grams
aqueous
laving
Prior art date
Application number
AT88305942T
Other languages
English (en)
Inventor
Herbert G Hechter
Original Assignee
E Z Em Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Z Em Inc filed Critical E Z Em Inc
Application granted granted Critical
Publication of ATE75141T1 publication Critical patent/ATE75141T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT88305942T 1987-07-10 1988-06-30 Waesserige abfuehrende loesung. ATE75141T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7186887A 1987-07-10 1987-07-10
EP88305942A EP0298655B1 (de) 1987-07-10 1988-06-30 Wässerige abführende Lösung

Publications (1)

Publication Number Publication Date
ATE75141T1 true ATE75141T1 (de) 1992-05-15

Family

ID=22104118

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88305942T ATE75141T1 (de) 1987-07-10 1988-06-30 Waesserige abfuehrende loesung.

Country Status (9)

Country Link
US (1) US4975286A (de)
EP (1) EP0298655B1 (de)
JP (1) JP2774106B2 (de)
AT (1) ATE75141T1 (de)
CA (1) CA1326454C (de)
DE (1) DE3870335D1 (de)
ES (1) ES2035292T3 (de)
GR (1) GR3004897T3 (de)
IL (1) IL86859A (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447763B1 (en) * 1998-06-12 2002-09-10 Ian L. Gordon Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells
RU2178696C2 (ru) * 2000-03-22 2002-01-27 Маткевич Виктор Анатольевич Энтеральная смесь для кишечного лаважа, коррекции метаболических расстройств организма, профилактики и лечения дисбактериоза кишечника
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
WO2005061008A1 (en) * 2003-12-01 2005-07-07 The United States Of America As Represented By The Secretary Of The Navy Bowel preparation for virtual colonscopy
US8435590B2 (en) * 2008-11-24 2013-05-07 Stokely-Van Camp, Inc. Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
NZ607043A (en) 2010-08-04 2015-05-29 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
CA2821196C (en) 2010-12-13 2022-11-22 Thomas Julius Borody Gastric and colonic formulations and methods for making and using them
BR112013019360A2 (pt) 2011-01-28 2017-03-28 A Shaver William ingredientes, componente seco de formulação oral de baixo teor de cloreto farmaceuticamente aceitável para limpeza de cólon, solução de base de reposição de eletrólito aquosa para uso em lavagem colônica, métodos para limpar os intestinos de paciente, para preparar solução aquosa para limpeza do cólon e para aumentar substancialmente o paladar de limpador de cólon e kits para evacuação do cólon.
CA2829385C (en) 2011-03-09 2021-07-13 Michael J. Sadowsky Compositions and methods for transplantation of colon microbiota
RU2473330C1 (ru) * 2011-12-09 2013-01-27 Александр Павлович Погромов Средство для кишечного лаважа
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
PT2877163T (pt) 2012-07-27 2019-05-24 Redhill Biopharma Ltd Formulações e métodos de fabrico de formulações para utilização na evacuação colónica
EP3563838A1 (de) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Doppelt verwendbare orale tabletten einer pharmazeutischen zusammensetzung aus sulfatsalzen und verfahren zur verwendung davon
BR112017024264B1 (pt) 2015-05-14 2022-07-12 Crestovo Holdings Llc Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
PT3297644T (pt) 2015-05-22 2022-03-30 Univ Arizona State Métodos para tratar distúrbios do espetro do autismo e sintomas associados
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (de) 2017-04-05 2020-02-12 Crestovo Holdings LLC Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit (pd) und verwandten erkrankungen
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders
AU2020316330A1 (en) 2019-07-19 2022-01-06 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993751A (en) * 1972-11-27 1976-11-23 Cybersol, Inc. Process for stabilizing therapeutic compositions and article
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
JP2509594B2 (ja) * 1985-08-01 1996-06-19 ブレインツリ−・ラボラトリ−ズ・インコ−ポレ−テッド 低ナトリウム緩下剤および洗浄剤処方

Also Published As

Publication number Publication date
JP2774106B2 (ja) 1998-07-09
CA1326454C (en) 1994-01-25
GR3004897T3 (de) 1993-04-28
IL86859A0 (en) 1988-11-30
EP0298655A3 (en) 1989-03-08
IL86859A (en) 1991-12-15
JPS6431724A (en) 1989-02-02
EP0298655B1 (de) 1992-04-22
EP0298655A2 (de) 1989-01-11
ES2035292T3 (es) 1993-04-16
DE3870335D1 (de) 1992-05-27
US4975286A (en) 1990-12-04

Similar Documents

Publication Publication Date Title
ATE75141T1 (de) Waesserige abfuehrende loesung.
EP0672418A3 (de) Verwendung eines Inhibitors der Adenosinmonophosphatdeaminase zur Erhöhung extracellularen Adenosins.
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
BE887373A (fr) Solution de conservation des globiles rouges contenant de l'adenine, un sucre, du chlorure de sodium et du mannitol
IT1154319B (it) Analizzatore di anidride carbonica nel flusso espiratorio finale per determinare la pressione parziale dell'anidride carbonica nel sangue arterioso di un paziente
FI103376B1 (fi) Laite potilaan sydämen tilavuusvirran parantamiseksi
UY25374A1 (es) Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina
AU584724B2 (en) Oxygenated fluorocarbon for use intra peritoneal perfusions
IT9067204A0 (it) Dispositivo per assistenza ventricolare cardiaca, particolarmente per il ricupero della funzione miocardica depressa e per il mantenimento delle funzioni vitali dell'organismo
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
ATE168003T1 (de) Badepräparat
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку
LV5660A3 (lv) Panemiens pretvirusu lidzekla iegusanai
IT8148348A0 (it) Procedimento per l'elettrolisi di una soluzione acquosa di cloruro al calino
CA1257595A (en) 5-HALOGEROVINYL-2'-DESOXYURIDINE DERIVATIVES
IT7951184A0 (it) Procedimento per l'elettrolisi di una soluzione acquosa di cloruro alcalino
GR3029357T3 (en) Method of preparing a radioactive rhenium complex solution.
SU1168252A1 (ru) Способ лечени больных псориазом
RU97111211A (ru) Способ лечения больных с хирургическим эндотоксикозом
FR2602261B1 (fr) Batiment destine a l'entrainement de personnes au port de masques respiratoires
UA30945A (uk) Спосіб лікування вірусної інфекції шкіри та слизових оболонок
ITMI931777A0 (it) Nuovi agenti per l'ossigenazione extracorporea del sangue
FR2384502A1 (fr) Composition organo-metallique medicamenteuse et son procede de fabrication
Wenzel et al. An acute experimental septicemia infection in mice caused by Sphaerophorus(Fusobacterium) necrophorus.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee